Neoadjuvant chemotherapy combined with bevacizumab for resectable colorectal liver metastasis with risk factors for recurrence: a multicenter real-world study
Neoadjuvant chemotherapy combined with bevacizumab for resectable colorectal liver metastasis with risk factors for recurrence: a multicenter real-world study
Jia Wu, Hangdong Jia, Zhenyuan Zhou, Linwei Xu et al.
Citations
4 citations
Journal
Therapeutic Advances in Medical Oncology
Topics
Colorectal Cancer Treatments and Studies
Field-Weighted Citation Impact (FWCI)
4.18
article
Neoadjuvant chemotherapy combined with bevacizumab for resectable colorectal liver metastasis with risk factors for recurrence: a multicenter real-world study
Jia Wu, Hangdong Jia, Zhenyuan Zhou, Linwei Xu, Rong Ye, Weijie Chen, Zheng Yuanyuan, Ming Zheng, Yizhen Chen, Yuhua Zhang
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
Therapeutic Advances in Medical OncologyVol. 17
Institutions
Fujian Medical University (CN), Zhejiang Cancer Hospital (CN), First Affiliated Hospital of Fujian Medical University (CN), Zhejiang Provincial People's Hospital (CN), Fujian Provincial Hospital (CN), Hangzhou Red Cross Hospital (CN), Hangzhou Medical College (CN), Putian University (CN), Fuzhou University (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Neoadjuvant chemotherapy combined with bevacizumab for resectable colorectal liver metastasis with risk factors for recurrence: a multicenter real-world study — Jia Wu, Hangdong Jia, et al. · Therapeutic Advances in Medical Oncology (2025) | TGRS Research Map | TGRS